Detalles de la búsqueda
1.
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.
Support Care Cancer
; 32(6): 335, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727834
2.
2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies.
Support Care Cancer
; 32(1): 30, 2023 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102373
3.
Reducing Recovery Times in Outpatient Liver Biopsies: Role of the GI Nurse.
Gastroenterol Nurs
; 45(4): 238-243, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833740
4.
Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.
Support Care Cancer
; 28(5): 2229-2238, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440823
5.
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
Oncologist
; 23(8): 889-e98, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29666296
6.
Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses.
Support Care Cancer
; 26(2): 557-564, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28871358
7.
A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.
J Neurooncol
; 134(2): 363-369, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28669010
8.
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
Support Care Cancer
; 24(10): 4365-75, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27271867
9.
Response to the letter to the Editor concerning manuscript entitled, "Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide".
Support Care Cancer
; 28(12): 5591-5592, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32885313
10.
Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
Support Care Cancer
; 22(7): 1897-905, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24570103
11.
Nurse practitioner satisfaction with in-person versus telehealth chronic care delivery.
J Am Assoc Nurse Pract
; 36(3): 160-170, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962429
12.
Hyperammonemia Secondary to 5-Fluorouracil.
J Adv Pract Oncol
; 14(5): 414-418, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37576363
13.
Music Intervention: Nonpharmacologic Method to Reduce Pain and Anxiety in Adult Patients Undergoing Bone Marrow Procedures.
Clin J Oncol Nurs
; 25(3): 314-320, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019034
14.
Utilizing a Palliative Care Screening Tool in Patients With Glioblastoma.
J Adv Pract Oncol
; 11(7): 684-692, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575065
15.
Improving Attitudes and Perceptions About End-of-Life Nursing on a Hospital-Based Palliative Care Unit.
J Hosp Palliat Nurs
; 21(4): 272-279, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30893285
16.
Development of a Professional Practice Model for Neuro-oncology Advanced Practitioners at an Academic Medical Center: A Quality Improvement Project.
J Adv Pract Oncol
; 9(5): 475-486, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-31086684
17.
Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma.
Semin Oncol Nurs
; 34(5): 472-485, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409554
18.
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.
Ther Clin Risk Manag
; 13: 33-40, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28096679
19.
Phase II trial of temozolomide in patients with progressive low-grade glioma.
J Clin Oncol
; 21(4): 646-51, 2003 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12586801
20.
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.
Neuro Oncol
; 6(2): 134-44, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15134628